N | Ganetespib-related grade 3 adverse events | Outcome |
---|---|---|
1a | Grade 3 blurred vision/grade 3 dry eyes (in same patient)a | Blurred vision: dose held for 1 week until ≤ grade 1 and paclitaxel dose reduced to 65 mg/m2/ Dry eyes: no action taken: resolved in 1 week |
1 | Grade 3 pruritus | While attributed to ganetespib, symptoms resolved after paclitaxel was held |
1 | Grade 3 phosphorus, decreased | No action taken; resolved in 1 day |
1 | Grade 3 ALT, increased | Ganetespib and paclitaxel dose held for 1 week; resolved in 1 week |